GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1
Open accessAbstract
Aims/hypothesis Accumulating evidence has revealed the significant role of glucagon-like peptide-1 (GLP-1) in weight loss. Sirtuin 1 (SIRT1) plays a vital role in the regulation of lipid metabolism. Here, we investigated the contribution of lipolytic and oxidative changes in white adipose tissue (WAT) to the weight-lowering effect induced by the GLP-1 receptor (GLP-1R) agonist exenatide (exendin-4) in mice. We also looked at the role of SIRT1 in this process.Methods C57BL/6J mice and Sirt1 (+/-) mice were treated with exenatide (24 nmol/kg) or an NaCl solution (154 mmol/l) control i.p. for 8 weeks while receiving a high-fat diet (HFD) after a 12 week HFD challenge. Systemic phenotypic evaluations were carried out during and after the intervention. A lentivirus-mediated short hairpin (sh)RNA vector of the Sirt1 gene was transfected into differentiated 3T3-L1 adipocytes. An in vitro model system used adipocytes induced from Sirt1-null mouse embryonic fibroblasts (MEFs).Results Exenatide reduced fat mass and enhanced the lipolytic and oxidative capacity of WAT in diet-induced obese C57BL/6J mice. However, these effects were significantly impaired in Sirt1 (+/-) mice compared with wild-type controls. In vitro, exendin-4 increased lipolysis and fatty acid oxidation by upregulating SIRT1 expression and activity in differentiated 3T3-L1 adipocytes. Conversely, RNA interference (i)-induced knockdown of SIRT1 attenuated the lipolytic and oxidative responses to exendin-4 in differentiated 3T3-L1 adipocytes. Again, these responses were entirely abolished in Sirt1-null MEFs after induction into adipocytes.Conclusions/interpretation These data highlight that a GLP-1R agonist promotes brown remodelling of WAT in a SIRT1-dependent manner; this might be one of the mechanisms underlying its effect on weight loss.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Liraglutide injected into mice stimulates thermogenesis of brown adipose tissue and browning of adipose cells independent of nutrient intake, and reduces lipid content through central GLP-1R signaling pathways.
“Beiroa (36) et al. injected GLP-1 analog, liraglutide (LIR), into mice. LIR was found to stimulate the thermogenesis of brown adipose tissue and the browning of adipose cells, independent of the intake of nutrients. It can increase the thermogenesis and utilization of triacylglycerol-derived fatty acids and glucose in brown adipocytes and reduce the lipid content through the central GLP-1R agonist”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [39]
GLP-1R appears to play a significant role in energy metabolism by directly promoting brown AT and mitochondrial bioenergetics remodeling.
“Recent research characterized the incretin system in fat tissue, and one intriguing finding was that GLP-1R appears to play a significant role in energy metabolism by directly promoting brown AT (BAT) and mitochondrial bioenergetics remodeling [94].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433 · see citing works
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707 · see citing works
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559 · see citing works
Adipose tissue browning and metabolic health
Bartelt, A., & Heeren, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.204 · Cited by 1,177 · see citing works
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163 · see citing works
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
Cheng, H.-L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F. W., & Chua, K. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934713100 · Cited by 1,095 · see citing works
Adaptive thermogenesis in adipocytes: Is beige the new brown?
Wu, J., Cohen, P., & Spiegelman, B. M. (2013) · Genes & Development · doi:10.1101/gad.211649.112 · Cited by 828 · see citing works
Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., ROSENBAUM, M. S., Zhao, Y., Gu, W. J., Farmer, S. R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.027 · Cited by 802 · see citing works
Barbatelli, G., Murano, I., Madsen, L., Hao, Q., Jimenez, M., Kristiansen, K., Giacobino, J., Matteis, R. D., & Cinti, S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00600.2009 · Cited by 751 · see citing works
Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719 · see citing works
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647 · see citing works
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., & Corvera, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21752 · Cited by 616 · see citing works
GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK
Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., et al. (2014) · Diabetes · doi:10.2337/db14-0302 · Cited by 602 · see citing works
GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
van Bloemendaal, L., IJzerman, R. G., ten Kulve, J. S., Barkhof, F., Konrad, R. J., Drent, M. L., Veltman, D. J., & Diamant, M. (2014) · Diabetes · doi:10.2337/db14-0849 · Cited by 427 · see citing works
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Nielsen, T. S., Jessen, N., Jørgensen, J. O. L., Møller, N., & Lund, S. A. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0277 · Cited by 380 · see citing works
Kanoski, S. E., Fortin, S. M., Arnold, M., Grill, H. J., & Hayes, M. R. (2011) · Endocrinology · doi:10.1210/en.2011-0174 · Cited by 347 · see citing works
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
van Bloemendaal, L., ten Kulve, J. S., la Fleur, S. E., Ijzerman, R. G., & Diamant, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0414 · Cited by 312 · see citing works
Jendle, J., Nauck, M. A., Matthews, D. R., Frid, A., Hermansen, K., Düring, M., Zdravkovic, M., Strauss, B. J., Garber, A. J., & Groups, O. B. O. T. L. A. L. S. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01158.x · Cited by 312 · see citing works
Adipocyte Mitochondrial Function Is Reduced in Human Obesity Independent of Fat Cell Size
Yin, X. L., Lanza, I. R., Swain, J. M., Sarr, M. G., Nair, K. S., & Jensen, M. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3042 · Cited by 226 · see citing works
Xu, F. L., Gao, Z., Zhang, J., Rivera, C. A., Yin, J., Weng, J., & Ye, J. (2010) · Endocrinology · doi:10.1210/en.2009-1013 · Cited by 221 · see citing works
Self-citationGaidhu, M. P., Fediuc, S., Anthony, N. M., So, M., Mirpourian, M., Perry, R. L. S., & Ceddia, R. B. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800480-jlr200 · Cited by 200 · see citing works
Wettergren, A., Wøjdemann, M., & Holst, J. J. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.5.g984 · Cited by 194 · see citing works
Nogueiras, R., Pérez-Tilve, D., Veyrat-Durebex, C., Morgan, D. A., Varela, L., Haynes, W. G., Patterson, J. T., Disse, E., Pfluger, P. T., López, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5977-08.2009 · Cited by 182 · see citing works
SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL
Chakrabarti, P., English, T., Karki, S., Qiang, L., Tao, R., Kim, J., Luo, Z., Farmer, S. R., & Kandror, K. V. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014647 · Cited by 179 · see citing works
Vendrell, J., El Bekay, R., Peral, B., García-Fuentes, E., Megia, A., Macias-Gonzalez, M., Real, J. F., Jimenez-Gomez, Y., Escoté, X., Pachón, G., et al. (2011) · Endocrinology · doi:10.1210/en.2011-1070 · Cited by 173 · see citing works
Richard, J. E., Anderberg, R. H., Göteson, A., Gribble, F. M., Reimann, F., & Skibicka, K. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119034 · Cited by 168 · see citing works
Andrade, J. M. O., Frade, A. C. M., Guimarães, J. B., Freitas, K. M., Lopes, M. T. P., Guimarães, A. L. S., de Paula, A. M. B., Coimbra, C. C., & Santos, S. H. S. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0655-6 · Cited by 168 · see citing works
Kooijman, S., Wang, Y., Parlevliet, E. T., Boon, M. R., Edelschaap, D., Snaterse, G., Pijl, H., Romijn, J. A., & Rensen, P. C. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3727-0 · Cited by 140 · see citing works
Diabetes Risk Among Overweight and Obese Metabolically Healthy Young Adults
Twig, G., Afek, A. B., Derazne, E., Tzur, D., Cukierman‐Yaffe, T., Gerstein, H. C., & Tirosh, A. (2014) · Diabetes Care · doi:10.2337/dc14-0869 · Cited by 116 · see citing works
SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis
Xu, F., Li, Z., Zheng, X., Liu, H., Liang, H., Xu, H., Chen, Z., Zeng, K., & Weng, J. (2014) · Diabetes · doi:10.2337/db14-0263 · Cited by 114 · see citing works
Self-citationBoschmann, M., Engeli, S., Dobberstein, K., Budziarek, P., Strauss, A., Boehnke, J., Sweep, F. C. G. J., Luft, F. C., He, Y., Foley, J. E., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1400 · Cited by 110 · see citing works
The role of AMP-activated protein kinase in regulating white adipose tissue metabolism
Ceddia, R. B. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.014 · Cited by 105 · see citing works
Mercader, J., Palou, A., & Bonet, M. L. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.007 · Cited by 96 · see citing works
Bertin, É., Arner, P., Bolinder, J., & Toft, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7330 · Cited by 83 · see citing works
Bi, Y., Zhang, B., Xu, W., Yang, H., Feng, W., Li, C., Tong, G., Li, M., Wang, X., Shen, S., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0638-3 · Cited by 71 · see citing works
Self-citationHeppner, K. M., Marks, S., Holland, J., Ottaway, N., Smiley, D., DiMarchi, R. D., & Pérez–Tilve, D. (2015) · Diabetologia · doi:10.1007/s00125-015-3651-3 · Cited by 44 · see citing works
Xu, C., Bai, B., Fan, P., Cai, Y., Huang, B., Law, I. K. M., Liu, L., Xu, A., Tung, C., Li, X., et al. (2013) · Europe PMC (PubMed Central) · Cited by 42 · see citing works
Jun, H., Joshi, Y., Patil, Y. N., Noland, R. C., & Chang, J. S. (2014) · Diabetes · doi:10.2337/db13-1837 · Cited by 33 · see citing works
Wei, Q., Li, L., Chen, J., Wang, S., & Sun, Z. (2015) · PubMed · Cited by 23 · see citing works
Kumar, K. L. A., & Marita, A. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703313 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950 · see citing works
The role of adipose tissue in cardiovascular health and disease
Oikonomou, E. K., & Antoniades, C. A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0097-6 · Cited by 509 · see citing works
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463 · see citing works
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 456 · see citing works
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
Bendotti, G., Montefusco, L., Lunati, M. E., Usuelli, V., Pastore, I., Lazzaroni, E., Assi, E., Seelam, A. J., El Essawy, B., Jang, J., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106320 · Cited by 406 · see citing works
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
Alharbi, S. H. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188231222367 · Cited by 358 · see citing works
Yan, J., Yao, B., Kuang, H., Yang, X., Huang, Q., Hong, T., Li, Y., Dou, J., Yang, W., Qin, G., et al. (2019) · Hepatology · doi:10.1002/hep.30320 · Cited by 260 · see citing works
Self-citationGLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Wang, J.-Y., Wang, Q.-W., Yang, X.-Y., Yang, W., Li, D.-R., Jin, J.-Y., Zhang, H.-C., & Zhang, X.-F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085799 · Cited by 248 · see citing works
Winiarska, A., Knysak, M., Nabrdalik, K., Gumprecht, J., & Stompór, T. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910822 · Cited by 195 · see citing works
The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.055 · Cited by 189 · see citing works
‘Browning’ the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk
Aldiss, P., Davies, G., Woods, R., Budge, H., Sacks, H. S., & Symonds, M. E. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.074 · Cited by 148 · see citing works
He, C., Cheng, D., Peng, C., Li, Y., Zhu, Y., & Lü, N. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00639 · Cited by 138 · see citing works
Fang, Y., Ji, L., Zhu, C., Xiao, Y., Zhang, J., Lu, J., Yin, J., & Wei, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602574 · Cited by 108 · see citing works
Ziqubu, K., Dludla, P. V., Mthembu, S. X. H., Nkambule, B. B., Mabhida, S. E., Jack, B. U., Nyambuya, T. M., & Mazibuko-Mbeje, S. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1114767 · Cited by 96 · see citing works
Li, Z., Zhang, B., Wang, N., Zuo, Z., Hong Kui, W. E. I., & Zhao, F. (2022) · Gut · doi:10.1136/gutjnl-2022-328035 · Cited by 83 · see citing works
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
Tamayo‐Trujillo, R., Ruiz‐Pozo, V. A., Cadena-Ullauri, S., Guevara‐Ramírez, P., Paz‐Cruz, E., Zambrano-Villacres, R., Simancas‐Racines, D., & Zambrano, A. K. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1398059 · Cited by 89 · see citing works
Peng, W., Zhou, R., Sun, Z., Long, J.-W., & Gong, Y.-Q. (2022) · Aging and Disease · doi:10.14336/ad.2021.0928 · Cited by 73 · see citing works
Autophagy-nutrient sensing pathways in diabetic complications
Parmar, U. M., Jalgaonkar, M. P., Kulkarni, Y. A., & Oza, M. J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106408 · Cited by 67 · see citing works
Xie, C., Jones, K. L., Rayner, C. K., & Wu, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090790 · Cited by 62 · see citing works
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
Geloneze, B., Júnior, J. C. D. L., & Velloso, L. A. (2017) · Drugs · doi:10.1007/s40265-017-0706-4 · Cited by 61 · see citing works
Młynarska, E., Bojdo, K., Bulicz, A., Frankenstein, H., Gąsior, M., Kustosik, N., Rysz, J., & Franczyk, B. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100787 · Cited by 80 · see citing works
Lim, J., Park, H. S., Kim, J., Jang, Y. J., Kim, J.-H., Lee, Y., & Heo, Y. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0528-4 · Cited by 56 · see citing works
Janssen, L. G. M., Nahon, K. J., Bracké, K. F. M., van den Broek, D., Smit, R., Sardjoe Mishre, A. S. D., Koorneef, L. L., Martinez-Tellez, B., Burakiewicz, J., Kan, H. E., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154167 · Cited by 54 · see citing works
Browning Epicardial Adipose Tissue: Friend or Foe?
Doukbi, E., Soghomonian, A., Sengenès, C., Ahmed, S., Ancel, P., Dutour, A., & Gaborit, B. (2022) · Cells · doi:10.3390/cells11060991 · Cited by 56 · see citing works
Ejarque, M., Guerrero-Pérez, F., de la Morena, N., Casajoana, A., Virgili, N., López-Urdiales, R., Maymó-Masip, E., Pujol Gebelli, J., Garcia Ruiz de Gordejuela, A., Perez-Maraver, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42770-1 · Cited by 53 · see citing works
Liu, Z., Gu, H., Gan, L., Xu, Y., Feng, F., Saeed, M., & Sun, C. (2016) · Oncotarget · doi:10.18632/oncotarget.14035 · Cited by 53 · see citing works
Opposite Regulation of Ghrelin and Glucagon-like Peptide-1 by Metabolite G-Protein-Coupled Receptors
Engelstoft, M. S., & Schwartz, T. W. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.07.001 · Cited by 52 · see citing works
Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu
Yaribeygi, H., Maleki, M., Reiner, Ž., Jamialahmadi, T., & Sahebkar, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216544 · Cited by 51 · see citing works
Ceddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 51 · see citing works
Li, W., Zhuang, T., Wang, Z., Wang, X., Liu, L., Luo, Y., Wang, R., Li, L., Huang, W., Wang, Z., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154982 · Cited by 49 · see citing works
GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?
Menghini, R., Casagrande, V., Rizza, S., & Federici, M. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02124-w · Cited by 47 · see citing works
Han, F., Hou, N., Liu, Y., Huang, N., Pan, R., Zhang, X., Mao, E.-W., & Sun, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109537 · Cited by 47 · see citing works
Lee, J.-Y., Lee, M., Lee, J. Y., Bae, J., Shin, E., Lee, Y., Lee, B., Kang, E. S., & Soo, B. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0187 · Cited by 46 · see citing works
The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts
Pal, S., Maurya, S. K., Chattopadhyay, S., China, S. P., Porwal, K., Kulkarni, C., Sanyal, S., Sinha, R. A., & Chattopadhyay, N. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.024 · Cited by 46 · see citing works
Vayghan, H. J., Varshosaz, P., Hajizadeh‐Sharafabad, F., Razmi, H., Amirpour, M., Tavakoli‐Rouzbehani, O. M., Alizadeh, M., & Maleki, V. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00503-6 · Cited by 43 · see citing works
Zhang, Y., Lin, Y., Li, G., Yuan, Y., Wang, X., Li, N., Xiong, C., Yang, Y., Ma, Y., Zhang, Z., et al. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad032 · Cited by 42 · see citing works
Ma, Z., Kong, C., Song, P. K., Zhang, X., Yuan, Y., & Tang, Q. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6053727 · Cited by 42 · see citing works
Urkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 40 · see citing works
An estrogen receptor α-derived peptide improves glucose homeostasis during obesity
Yang, W., Jiang, W., Liao, W., Yan, H., Ai, W., Pan, Q., Brashear, W. A., Xu, Y., He, L., & Guo, S. (2024) · Nature Communications · doi:10.1038/s41467-024-47687-6 · Cited by 38 · see citing works
Zhang, J., Wu, H., MA, S., Jing, F., Yu, C., Gao, L., & Zhao, J. (2018) · Physiological Research · doi:10.33549/physiolres.933650 · Cited by 38 · see citing works
Beige Adipocyte as the Flame of White Adipose Tissue: Regulation of Browning and Impact of Obesity
Altınova, A. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab921 · Cited by 39 · see citing works
Maciel, M. G., Beserra, B. T. S., Oliveira, F. C. B., Ribeiro, C. M., Coêlho, M. S., Neves, F. D. A. R., & Amato, A. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.034 · Cited by 36 · see citing works
Zhu, R., & Chen, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1095432 · Cited by 36 · see citing works
Cao, H., Cai, Q., Guo, W., Su, Q., Qin, H., Wang, T., Xian, Y., Zeng, L., Cai, M., Guan, H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112319 · Cited by 35 · see citing works
Self-citationAdipose Tissue in Cardiovascular Disease: From Basic Science to Clinical Translation
Polkinghorne, M., West, H. W., & Antoniades, C. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-021346 · Cited by 34 · see citing works
Bae, J. H., Choi, H. J., Cho, K. I. K., Kim, L. K., Kwon, J. S., & Cho, Y. M. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0018 · Cited by 33 · see citing works
Wan, Y., Bao, X., Huang, J., Zhang, X., Liu, W., Cui, Q., Jiang, D., Wang, Z., Liu, R., & Wang, Q. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00294 · Cited by 33 · see citing works
Xu, F., Cao, H., Chen, Z., Gu, H., Guo, W., Lin, B., & Weng, J. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0513-y · Cited by 31 · see citing works
Self-citationSon, M., Oh, S., Lee, H. S., Chung, D.-M., Jang, J. T., Jeon, Y., Choi, C. H., Park, K. Y., Son, K. H., & Byun, K. (2019) · Nutrients · doi:10.3390/nu11112795 · Cited by 31 · see citing works
Oliveira, F. C. B., Bauer, E. J., Ribeiro, C. M., Pereira, S. A., Beserra, B. T. S., Wajner, S. M., Maia, A. L., Neves, F. A. R., Coelho, M. S., & Amato, A. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.803363 · Cited by 30 · see citing works
Wang, Y., He, W., Wei, W., Mei, X., Yang, M., & Wang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.622737 · Cited by 30 · see citing works
Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential
AL-Noshokaty, T. M., Abdelhamid, R., Abdelmaksoud, N. M., Khaled, A., Hossam, M., Ahmed, R., Saber, T., Khaled, S., Elshaer, S. S., & Abulsoud, A. I. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101895 · Cited by 30 · see citing works
Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes
Góralska, J., Śliwa, A., Gruca, A., Raźny, U., Chojnacka, M., Polus, A., Solnica, B., & Malczewska-Malec, M. (2017) · Acta Biochimica Polonica · doi:10.18388/abp.2017_1634 · Cited by 30 · see citing works
Brown and beige adipose tissue: New therapeutic targets for metabolic disorders
Magro, B. S., & Dias, D. P. M. (2024) · Health Sciences Review · doi:10.1016/j.hsr.2024.100148 · Cited by 32 · see citing works
Wang, X., Chen, J., Rong, C., Pan, F., Zhao, X., & Hu, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.197 · Cited by 29 · see citing works
Laminarin counteracts diet-induced obesity associated with glucagon-like peptide-1 secretion
Yang, L., Wang, L., Zhu, C., Wu, J., Yuan, Y., Yu, L., Xu, Y., Xu, J., Wang, T., Liao, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19957 · Cited by 27 · see citing works
Zeng, W., Tang, J., Li, H., Xu, H., Lu, H., Peng, H., Lin, C., Gao, R., Lin, S., Lin, K., et al. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.013 · Cited by 27 · see citing works
Self-citationThe Impact of Incretin-Based Medications on Lipid Metabolism
Yaribeygi, H., Maleki, M., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/1815178 · Cited by 27 · see citing works
Adipose Tissue Composition in Obesity and After Bariatric Surgery
Adami, G. F., Carbone, F., Montecucco, F., Camerini, G. B., & Cordera, R. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04030-z · Cited by 26 · see citing works
Reynés, B., Palou, M., & Palou, A. (2016) · Food & Function · doi:10.1039/c6fo01473a · Cited by 26 · see citing works
Kononova, Y. A., Тучина, Т. П., & Babenko, A. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413295 · Cited by 28 · see citing works
Osuna‐Prieto, F. J., Martínez‐Téllez, B., Segura‐Carretero, A., & Ruiz, J. R. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab084 · Cited by 25 · see citing works
Liraglutide improves lipid and carbohydrate metabolism of ovariectomized rats
Model, J. F. A., Lima, M. V., Ohlweiler, R., Vogt, É. L., Rocha, D. S., de Souza, S. K., Türck, P., Araújo, A. S. D. R., & Vinagre, A. S. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111158 · Cited by 23 · see citing works
Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice
Azushima, K., Uneda, K., Wakui, H., Ohki, K., Haruhara, K., Kobayashi, R., Haku, S., Kinguchi, S., Yamaji, T., Minegishi, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42657-1 · Cited by 22 · see citing works
DPP-IV as a potential candidate in anti-obesity and obesity-related diseases treatment
Guo, X., Feng, H., Cai, L., Zheng, J., & Li, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117464 · Cited by 21 · see citing works
Nowrouzi‐Sohrabi, P., Rezaei, S., Jalali, M., Ashourpour, M., Ahmadipour, A., Keshavarz, P., & Akbari, H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173823 · Cited by 21 · see citing works
Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way
Guo, W., Liu, J., Cheng, L., Liu, Z., Zheng, X., Liang, H., & Xu, F. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.704112 · Cited by 21 · see citing works
Self-citationZhao, Y.-F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.956277 · Cited by 21 · see citing works
Li, Y., Fang, Y., Wang, H., & Zhang, H. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2906208 · Cited by 21 · see citing works
Effects of antidiabetic drugs on epicardial fat
Xourgia, E., Papazafiropoulou, A. K., & Melidonis, A. J. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i9.141 · Cited by 21 · see citing works
Mechanisms and pharmacotherapy of cancer cachexia‐associated anorexia
Sato, R., da Fonseca, G. W. P., das Neves, W., & von Haehling, S. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70031 · Cited by 21 · see citing works
Beaudry, J. L., & Drucker, D. J. (2019) · Endocrinology · doi:10.1210/endocr/bqz029 · Cited by 20 · see citing works
Spatiotemporal control of GLP-1 receptor activity
Manchanda, Y., Bitsi, S., Kang, Y., Jones, B. J., & Tomás, A. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.07.003 · Cited by 20 · see citing works
Quagliariello, V., Canale, M. L., Bisceglia, I., Iovine, M., Giordano, V., Giacobbe, I., Scherillo, M., Gabrielli, D., Maurea, C., Barbato, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011299 · Cited by 20 · see citing works
Pharmacological modulation of adaptive thermogenesis: new clues for obesity management?
Genchi, V. A., Palma, G., Sorice, G. P., D’Oria, R., Caccioppoli, C., Marrano, N., Biondi, G., Caruso, I., Cignarelli, A., Natalicchio, A., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02125-0 · Cited by 19 · see citing works
GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions
Li, H., Donelan, W., Wang, F., Zhang, P., Yang, L., Ding, Y., Tang, D., & Li, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.777026 · Cited by 18 · see citing works
Shipp, S. L., Cline, M. A., & Gilbert, E. R. (2016) · Adipocyte · doi:10.1080/21623945.2016.1208867 · Cited by 18 · see citing works
Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis
Williams, J., Camarda, R., Malkov, S., Zimmerman, L. J., Manning, S., Aran, D., Beardsley, A. R., de Mark, D. V., Nakagawa, R. M., Chen, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62486-3 · Cited by 17 · see citing works
Exenatide mitigates inflammation and hypoxia along with improved angiogenesis in obese fat tissue
Xian, Y., Chen, Z., Deng, H., Cai, M., Liang, H., Xu, W., Weng, J., & Xu, F. L. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0639 · Cited by 17 · see citing works
Self-citationXie, C., Wang, X., Jones, K. L., Horowitz, M., Sun, Z., Little, T. J., Rayner, C. K., & Wu, T. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13906 · Cited by 17 · see citing works
De Fano, M., Malara, M., Vermigli, C., & Murdolo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168650 · Cited by 17 · see citing works
Shantaram, D., Rima, X. Y., Bradley, D. P., Liu, J. Z., Wright, V. P., AMARI, A., Jalilvand, A., Rottinghaus, J., Fernandes, J. M., Smith, A. J., et al. (2025) · Diabetes · doi:10.2337/db24-0861 · Cited by 16 · see citing works
AlZaim, I., Eid, A. H., Abd‐Elrahman, K. S., & EL‐Yazbi, A. F. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115337 · Cited by 16 · see citing works
Brown, J. D., McAnally, D., Ayala, J. E., Burmeister, M. A., Morfa, C. J., Smith, L. H., & Ayala, J. E. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00459.2017 · Cited by 16 · see citing works
D-allulose ameliorates adiposity through the AMPK-SIRT1-PGC-1α pathway in HFD-induced SD rats
Lee, G., Peng, C. Y., Lee, H., Park, S., Hoang, T., Kim, J., Sa, S., Kim, G., Han, J.-S., & Chae, H. (2021) · Food & Nutrition Research · doi:10.29219/fnr.v65.7803 · Cited by 16 · see citing works
Cardiovascular disease leads to a new algorithm for diabetes treatment
Rodriguez, V., Weiss, M. C., WEINTRAUB, H. S., Goldberg, I. J., & Schwartzbard, A. Z. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.07.004 · Cited by 15 · see citing works
Bakkar, N. Z., AlZaim, I., & EL‐Yazbi, A. F. (2022) · Clinical Science · doi:10.1042/cs20220404 · Cited by 15 · see citing works
Fighting Type-2 Diabetes: Present and Future Perspectives
Yu, C., Fu, Y., Fang, Y., Zhang, N., Sun, R., Zhao, D., Feng, Y., & Zhang, B. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666171009115356 · Cited by 15 · see citing works
Zhao, L. Q., Li, W., Zhang, P., Wang, D., Yang, L., & Yuan, G. (2024) · Endocrine · doi:10.1007/s12020-024-03734-2 · Cited by 14 · see citing works
Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes
Kuriyama, T., Ishibashi, C., Kozawa, J., Baden, M. Y., Horii, T., Niki, A., Ozawa, H., Hosokawa, Y., Fujita, Y., Sadahiro, K., et al. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.12.005 · Cited by 14 · see citing works
From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists
Dave, B. P., Chorawala, M. R., Shah, I., Shah, N. N., Bhagat, S. U., Prajapati, B. G., & Thakkar, P. C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09793-y · Cited by 12 · see citing works
Beyond obesity – thermogenic adipocytes and cardiometabolic health
Aldiss, P., Dellschaft, N. S., Sacks, H. S., Budge, H., & Symonds, M. E. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0007 · Cited by 11 · see citing works
Alves, P. L., Abdalla, F. M. F., Alponti, R. F., & Silveira, P. F. (2017) · Toxicon · doi:10.1016/j.toxicon.2017.06.001 · Cited by 11 · see citing works
Masashi, I. I. D. A., & Asano, A. (2024) · Journal of Veterinary Medical Science · doi:10.1292/jvms.24-0042 · Cited by 11 · see citing works
Zhao, L., Li, F., Zhang, X., Tian, H., Ma, Z., Yang, X., Zhang, Q., Pu, M., Cao, P., Zhang, D., et al. (2025) · Animals · doi:10.3390/ani15111569 · Cited by 10 · see citing works
Liaqat, I., Naseem, S., Eijaz, S., Hanif, U., Rubab, S., Aftab, M. N., & Iqbal, R. (2021) · Journal of Oleo Science · doi:10.5650/jos.ess21148 · Cited by 10 · see citing works
Targeting obesity for therapeutic intervention in heart failure patients
Sato, R., & von Haehling, S. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2363395 · Cited by 10 · see citing works
Overexpression of METTL14 mediates steatohepatitis and insulin resistance in mice
Zhou, J., Yang, M., Zhai, D.-G., Jiang, Q. L., & Zhang, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35467 · Cited by 9 · see citing works
The expanding role of semaglutide: beyond glycemic control
Zarei, M., Sabetkasaei, M., Mozafari, M., & Zaeri, S. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01663-z · Cited by 9 · see citing works
Liu, Z., Chen, Y., Su, Y., PENG, Y., Xu, F. L., Yao, B., Liang, H., Lin, B., & Xu, W. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05844-0 · Cited by 9 · see citing works
Self-citation
- Authors
- Xu, F., Lin, B., Zheng, X., Chen, Z., Cao, H., Xu, H., Liang, H., & Weng, J.
- Affiliations
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Key Laboratory of Guangdong Province (CN)
- Corresponding author
- Weng, Jianping
- Venue
- Diabetologia
- Published
- 2016-02-29
- Volume
- 59
- Issue
- 5
- Pages
- 1059-1069
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2288966387
- Cited by
- 157
- References
- 40
- Citations by year
- 2026: 18 · 2025: 22 · 2024: 21 · 2023: 17 · 2022: 14 · 2021: 14 · 2020: 14 · 2019: 11 · 2018: 13 · 2017: 8 · 2016: 5
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- the National Natural Science Foundation of China Grant Award (81300705)
- PCSIRT (82000-18811100)
- the Program for ‘973’ project (2012CB517506)
- NSFC-CIHR (81261120565)
- Topics
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- GLP-1 receptor agonists, exenatide, SIRT1, white adipose tissue, lipolysis, fatty acid oxidation, oxidative metabolism, weight loss, diet-induced obesity, high-fat diet, adipocytes, 3T3-L1 adipocytes, SIRT1 knockout mice
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Exenatide, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Body Weight, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Obese, Peptides, Venoms, Lipid Metabolism, Mice, Adipose Tissue, White, Sirtuin 1, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review